ACTIVE IMMUNIZATION OF MICE WITH THE POLYSACCHARIDES OF PNEUMOCOCCI TYPES I, II AND III by Zozaya, José & Clark, Janet
ACTIVE  IMMUNIZATION  OF  MICE  WITH  THE  POLYSAC- 
CHARIDES  OF  PNEUMOCOCCI  TYPES  I,  II  AND  III 
BY JOS]~ ZOZAYA, M.D., AND JANET CLARK 
(From the Mulford Biological Laboratories, Sharp and Dohme, Glenolden, 
Pennsylvania) 
(Received for publication, August 3, 1932) 
A great deal of contradictory evidence has been reported in the study of the 
polysaccharides  of the  pneumococci  as  antigens.  Avery and  Morgan  (1)  and 
Avery  and  Heidelberger  (2)  failed  to  induce  antibody  formation in  animals 
injected  with  their  purified  polysaccharides.  Schiemann  and  his  coworkers 
(3-5) obtained a carbohydrate from the pneumococcus ceils by a different method 
from that  used  by Heidelberger and  Avery, but  believed  that  the  substance 
obtained  was  identical  with  that  of  the  last  mentioned  authors.  With  this 
substance  they  were  able  to  produce  active  type-specific  immunity  in  mice, 
although no precipitins were found in rabbits so treated.  Enders (6) has obtained 
a distinct polysaccharide (substance  A) from pneumococci Type I, and with this 
substance was able to produce typical anaphylactic shock in guinea pigs passively 
sensitized  with serum containing only antibody against this A substance.  The 
characteristic behavior of this substance A is that its activity both in vitro and as an 
immunizing  antigen is greatly diminished  or lost by heating in a weak alkaline 
solution.  Wadsworth and Brown (7) reported the isolation of a specific substance 
from the Pneumococcus Type I cell disrupted by repeated freezing and thawing. 
This substance,  of carbohydrate nature, precipitates specifically its homologous 
type serum in a high dilution.  With the same serum, after the antibodies against 
the  specific  carbohydrate of  Heidelberger and  Avery,  prepared  from  culture 
filtrates,  had been absorbed,  ten times the amount was required for precipitation. 
This  substance  injected into  mice in  the  same  amounts  used  by  Schiemann, 
immunized  them against Pneumococcus  Type I  virulent culture. 
Zozaya (8) has reported work on the production of active immunity 
in mice,  rabbits  and  horses with  the  specific polysaccharides of the 
three types of pneumococci adsorbed on colloids.  In the present study 
we  are  reporting further work  on  the  active immunity produced in 
mice  by  the  injection  of  the  three  specific  polysaccharides  of  the 
pneumococci, adsorbed on colloids and alone. 
21 22  POLYSACCHARIDES  OF  PNEUMOCOCCI 
Metkod 
Preparation  of Colloid Carrier and  Adsorption  of Polysaccharide on  Collodion 
Particles  and  Carbon.--The  methods  used  for  the  preparation of  the  collodion 
carrier and adsorption of the p01ysaccharides were the same described in a previous 
communication  (8).  The  adsorbed  collodion particles  were  rid  of  free  poly- 
saecharide by washing unless otherwise stated,  and  standardized so  that  their 
turbidity would equal that  of a  suspension of B. coti of 25,000,000,000  per cc. 
The suspension of collodion particles upon which the polysaccharides have been 
adsorbed will be designated merely as  collodion particles of whatever polysac- 
charide was used for the adsorption. 
The  adsorption  of  polysaccharide on  carbon  and  the  determination  of  the 
amount of polysaccharide irreversibly adsorbed have been described in a previous 
study  (9).  The suspensions of adsorbed carbon were standardized according to 
the  amount  of polysaccharide adsorbed,  35  rag.  SSS  Pneumococcus  I  61002-1 
per gm. of carbon and 22.5 mg. SSS Pneumococcus III 61153 per gin. of carbon, 
so that they contained per co. specific carbohydrate equivalent to a certain dilution 
of the polysaceharide in solution. 
Bacterial Potysacckarides.--Various  preparations of specific carbohydrate from 
Pneumococcus Type I, II and III of varying purity were used in the course of 
study.  Polysaccharides of Pneumococcus Type I, II and III were kindly supplied 
by Dr. M. Heidelberger and will be designated as SSS Pneumococcus I  H,  SSS 
Pneumococcus II H  and SSS Pneumococcus III H. 
The polysaccharides of Pneumococcus Type I  designated SSS Pneumococcus 
I  M  and  No.  61002-1  were prepared by us according to  a  method  previously 
described by Heidelberger, Sia and Kendall (10).  The polysaccharide of Pneumo- 
coccus Type I designated SSS Pneumococcus I  F and that of Pneumococcus Type 
II  designated  SSS  Pneumococcus  II  G  were  prepared  according  to  the  same 
method with the exception that the precipitation at the isoelectric point was not 
carried  out,  the  only  purification  being  that  of  repeated  reprecipitation with 
alcohol.  The polysaccharide of Pneumococcus Type III, No. 61153, was prepared 
according to the method of Heidelberger and Avery (11) for the preparation of the 
nitrogen-free specific carbohydrate of Pneumococcus Type III. 
None of these polysaccharides were obtained in sufficient amount for chemical 
analysis but all precipitated specifically their homologous serums in dilutions of 
1 : 5,000,000  to  1 : 6,000,000. 
Immunization of Animals.--Mice,  17 to 19 gm. in weight, were injected by the 
intraperitoneal route unless otherwise mentioned.  Either a  single injection was 
employed or 1 injection weekly for a number of weeks as stated. 
Protection  Tests.--Animals  were  tested  for  immunity  by  the  intraperitoneal 
injection in serial dilutions, of young cultures of Pneumococcus Type I, II and III 
of maximum virulence.  The virulence of the culture was controlled by simultane- 
ous injection into normal untreated mice.  Immunity was considered as demon- 
strated if the mouse survived the injection of ten or more minimal fatal doses for 
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Immunization  with  Collodion  Particles  Adsorbed  with  Pneumococcus 
Type I, H  and III Polysaccharldes 
Type I.--A washed suspension of collodion particles adsorbed with 
Pneumococcus Type I  polysaccharide M, was injected into mice by 
various routes, intravenously, intraperitoneally and subcutaneously. 
One group received 0.5 cc. of a 25,000 million suspension by each route, 
the other 0.5 cc. of a 50,000 million suspension by the same routes.  In 
TABLE  I 
Influence of Route and Quantity on the Immunixation of Mice with Collodion Particles 
Adsorbed with Type I Pneumococcu, Polysaccharide M 
Dose of collodion 
particles SSS 
Pneumococcus I M, 
measured by density 
of suspension 
0 
(normal control 
mice) 
12,500 M 
25,000 M 
Dose of 
Pneumo- 
coccus 
culture 
received 
7 days later 
cc. 
I0-' 
lO-S 
I0-~ 
I0  ~ 
I0-~ 
10  ~ 
I0  ~ 
I0  ~ 
I0-* 
Route of immunizing injection 
Intravenously  Intraperltoneally  Subcutaneously 
36 
s 
36 
S  S 
S  S 
96  S 
S  S 
S  -- 
S  S 
S 
S 
24 
s 
S 
S 
S 
S 
S 
S 
S  =  survived. 
Numeral = died, hours. 
--  ffi not done. 
the results as shown in Table I one can notice that the degree of active 
immunity induced, irrespective of the route of injection, was sufficient 
to  withstand  the  injection  of  1,000  to  10,000  M.~.I).  No  greater 
immunity was produced by the use of a double strength suspension. 
The intraperitoneal route and a dose of 0.5 cc.  of a 25,000  million 
suspension of adsorbed collodion particles was adopted as our standard 
in the further immunological study. 
In order to determine the time interval required for development of 24  POL~SACCI~kRIDES  O~"  PNEUMOCOCCI 
immunity following the injection of collodion particles adsorbed with 
Pneumococcus  Type  I  polysaccharide,  groups  of mice  were  injected 
with collodion partides SSS Pneumococcus I  M  and tested after various 
intervals for immunity against virulent Pneumococcus Type I  culture. 
Definite  immunity  was  found  to  have  developed  within  4  days,  in- 
TABLE  II 
Time Factor in the Immuniza2ion of Mice with Collodion Particles Adsorbed with 
Pneumococcus Type I  Polysaccharide 
Amount  of collodion 
particles SSS Pneumo- 
coccus  I, measured by 
density of suspension 
0 
(normal  control 
mice) 
12,500 M 
2 injectionsof  12,500 
M  at  weekly in- 
tervals 
3 injections of 12,50C 
M  at  weekly in- 
tervals 
'neumo- 
COCCUS 
Type I 
culture 
dose 
CC. 
10-9 
10-s 
10-r 
10-s 
10-5 
10-4 
10-2 
i0-~ 
10-4 
lO-S 
10-2 
10-5 
10-4 
lO-S 
10-2 
Interval between  last immunizing  injection and test for immunity 
4 days  I wk.  ;. 
S  S  -SS-- 
S  -  3636 - 
3~  --136136--I 
S  S  S]36[S]S 
72  S  S[36[S[S 
o 
S  S 
18 22 
96SS 
SSS 
18 24 24' 
[18/18124 
2 wk 
SS 
24 36 
36]36 
36! S 
Z21 S 
S]  S 
~2172 
361  S 
18] S 
18124, 
t8118 
! 
)6]  S 
sl  s! 
)6  S 
-- 148 48 
--  48  48  -- 
--  48 48 
$36  S S 
$36  S  S 
S  24 24 36 
sh8 is 
$96  S 
SSS 
S 18 48 
SSSS 
SSSS 
$36  S  S 
wL s.  4 wks. 
--  S~  ST-- 
181481- 
181481 -- 
Sl 
241 
sl 
181481 
SI Si-- 
181961 - 
181481- 
l 
sI SI S 
361361 S 
18120I  - 
361 S  S 
s I s I s 
18 36136 
18 18 -- 
S  =  survived. 
Numeral  =  died, hours. 
-  --  not  done. 
creasing  by  the  7th  day  and  reaching  its  height  in  about  2  weeks 
(Table II).  Following 2 or 3 weekly injections this immunity is more 
regular  and more marked  for a  longer period after the final injection. 
In  all groups, however, a  decrease  in  immunity  was  shown  after  an 
interval  of 4  weeks. 
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particles  adsorbed  with  Pneumococcus Type  I  polysaccharide was 
demonstrated by dividing into three groups a series of mice injected 7 
days before with collodion particles SSS  Pneumococcus I  M.  One 
group then received live virulent cultures of Pneumococcus Type I, 
another of Type II and the third of Type III.  The mice were pro- 
tected against a dose of the Pneumococcus Type I  culture equivalent 
to  100,000  ~t.F.D. but showed no immunity against the Type II or 
Type III organisms as shown in Table III. 
TABLE  III 
Type Specificity in the Immunization of Mice with Collodion Particles Adsorbed with 
Pneumococcus Type I  Polysaccharide 
tmount of collodion 
particles  SSS 
Pneumococcus I M 
received  7 days 
before, measured 
by density of 
suspension 
0 
normal control 
mice) 
12,500 M 
CC. 
10-9 
lO-S 
10-7 
10-~ 
10-4 
10-3 
Pneumococcus 
Type I 
36  S 
36  36 
36  36 
36  S 
36  36 
20  S 
Pneunlococcu$ 
Type II 
--  10 -9  48  ,  48  .  --. 
--  10  -s  48  48  ,  --. 
--  10  -7  24  ,  48  -  --- 
i 
I 
S  10 -7  24  ]48 
I 
S  10 -s  24  ]24 
S  10 -5  24  [24  I 
Pneumococcus 
Type III 
CC. 
10  -9  36  S 
10 -8  36  72 
10 -7  36  S 
48  10 -~  36  36 
48  10 ~  36  36 
48  10 ~  20  36 
36 
36 
S  =  survived. 
Numeral  =  died, hours. 
--  -- not done. 
These findings closely correspond with  those in  mice following a 
single  intraperitoneal  injection  of  formalin-killed  Pneumococcus 
Type I  organisms both in the time interval necessary (3 to 7 days) 
and the specificity.  The optimum dosage of 0.5 cc. of a  suspension 
of 100 million organisms per cc. for this single injection is of special in- 
terest in view of later findings. 
Type//.--Collodion  particles adsorbed with Pneumococcus Type II 
polysaccharide  G  and  washed  five  times,  were  injected  intraperi- 
toneally into mice which were tested 7 days after the final injection 
for immunity against live virulent Pneumococcus Type II.  After a 26  POLYSACCHARIDES  OF  PNEUMOCOCCI 
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single injection immunity to 10 M.F.D. of Pneumococcus Type II was 
demonstrated.  Following 2, 3 or 4 injections at weekly intervals this 
increased to a protection against 1,000 to 1,000,000 ~r.F.D. (Table IV). 
Such immunity as induced by 1 injection of collodion particles SSS 
II  G  is  specific,  no  protection  being  shown against  Pneumococcus 
Type I  (Table V). 
Collodion  particles  adsorbed  with  pneumococcus  polysaccharide 
Type II H,  however, produced no demonstrable immunity in mice. 
TABLE  V 
Type  Specificity  in  the  Immunization  of Mice with Collodion Particles  Adsorbed 
with Pneumococcus Type II Polysaccharide 
Amount of collodion 
particles SSS 
Pneumococcus II G  received 7 days  Pneumococcus  Pneumococcus 
before, measured  Type I  Type II 
by density of 
suspension 
0 
(normal control 
mice) 
12,500 M 
Cg. 
I0-9 
10-s 
i0-, 
lO-S 
I0-~ 
lO-S 
10-5 
48  S  S  -- 
48  48  48  -- 
48  48  48  -- 
48  48  48  72 
48  48  48  48 
48  48  48  48 
48  48  48  48 
m  __ 
72  S 
72  s 
48 
48 
CC. 
10-9 
lO-S 
lO-r 
10-8 
10-7 
10-~ 
i0-~ 
8  S  -- 
48  -- 
48  48  -- 
48  S  S 
48  48  4~ 
20  48  4[ 
20  24  4[ 
m 
m 
S 
4~ 
4~ 
4~ 
m  __ 
s  s 
S  S 
48  48 
S  S 
S  =  survived. 
Numeral  =  died, hours. 
--  =  not done. 
This will be  discussed further in connection with the immunization 
with the various polysaccharides in solutions. 
Type  III.--Collodion  particles  adsorbed  with  pneumococcus 
polysaccharide Type III H  also produced no immunity against live 
virulent  organisms  of  the  homologous type.  A  definite immunity 
was demonstrable against the heterologous Type I  culture but none 
against Type II (Table VI). 28  POLYSACCHARIDES  OF  PNEUMOCOCCI 
TABLE  VI 
Immunization of Mice with Collodion Particles Adsorbed with Pneumococcua Type 
III Polysaccharide 
Dose of collodion 
particles SSS 
Pneumococcus III H 
received each injec- 
tion, measured in 
density of suspension 
0 
(normal  control 
mice) 
12,500 M 
0 
(normal  control 
mice) 
12,500 M 
Dose of 
culture 
received 
7 days after 
last injection 
¢C. 
I0-9 
lO-S 
10-~ 
10-8 
I0-' 
10-o 
lO-S 
10-4 
10-9 
lO-S 
10-r 
10-8 
10-7 
No. of weekly immunizing injections received 
'  I  ~  I  3  , 
Pneumococcus Type I 
48 
48 
48 
48 
48 
S 
48 
S  S 
48 
48  s 
48  48 
~8~ 
48 
48 
48 
S 
--  S 
S 
S 
S 
72  48 
~  48 
48 
S  S 
S  S 
S 
S 
Pneumococcus Type II 
7] 
4~ 
4~ 
0 
(normal  control 
mice) 
12,500 M 
 llls148 48S 
S8  48  48  24  24 
48  48  48  48  24  48 
48  48  48  48  48  48  48  48  48  -- 
48  48  48  48  48  S  24  48 
Pneumococcus Type III  ss  ~s 
S 
S  S  --  10 48]  48  I  lo8  2~  48~ 
10 -7  24  24  48  48 
10 -s  24  48:8  48  48:4 
10 -~  24  48  24  24 
10  -~  24  48  48  48 
sis 
S  ~s 
~s 
48  9s6 
S  =  survived. 
Numeral  =  died, hours. 
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The Effect of Free Polysaccharide in Unwashed Suspensions of Collodion 
Particles Adsorbed with Pneumococcus  Type I  and H  Polysac- 
charide on the Production  of Active Immunity in Mice 
Since control mice injected with  1:1,000 or 1:10,000 solutions of 
pneumococcus polysacchafides Type I, II and III had failed to show 
immunity (8)  the  immunity induced by  the  injection of collodion 
particles adsorbed with Pneumococcus Type I  and II polysaccharide 
was  attributed  to  the  polysaccharide-colloid  combination.  The 
minute amount of polysaccharide necessary  for  the  production of 
immunity was demonstrated by calculating the approximate amount 
of polysaccharide adsorbed on the collodion particle. 
It has now been found that if animals are injected with collodion 
particles  adsorbed  with  pneumococcus polysaccharide  Type  I  or 
Type II  and not washed free of unadsorbed polysaccharide a very 
different result will be obtained.  No immunity was induced by the 
injection of unwashed collodion particles SSS Pneumococcus I  M  or 
collodion particles SSS II G, whereas a  slight immunity was demon- 
strated following the injection of the same collodion particles washed 
free of unadsorbed polysaccharide. 
The  optimum concentration for  immunization of  polysaccharide 
solution mixed with collodion particles for adsorption, the excess not 
being removed, was determined for both Type I and Type II pneumo- 
coccus polysaccharides.  Whereas in the regular preparation of ad- 
sorbed collodion particles these were exposed to a 1 : 100 solution of the 
polysaccharide, in this series they were suspended in the same density 
(25,000,000,000  per  cc.)  in  dilution  of  the  polysaccharide  ranging 
from a  1"1,000 to a  1:5,000,000.  The 1:1,000,000 and 1:5,000,000 
SSS Pneumococcus  I M collodion particles were found to be as effective 
immunizing antigens as the washed collodion particles SSS Pneumo- 
coccus I  M  and  superior to  the  collodion particles in  the  stronger 
dilutions  (Table  VII). 
Immunization  with Pneumococcus  Type I, H  and IH  Polysaccharide 
Solutions 
The results of these tests led us to investigate our previous failure 
to  induce  immunity against  Pneumococcus Type  I  or  II  by  the 30  POLYSACCHARIDES  OF  PNEUMOCOCCI 
TABLE  VII 
Immunization  of Mice with Collodion Particles Adsorbed with Type I  Pneumococcus 
Potysacckarides; Optimum Concentration of Polysaccharides, Free  Excess 
Not Being Removed 
Dose of 
Collodion particles  Pneumo-  Collodion particles  coccus  I  12,500 M in dilution  culture  12,500 M in dilution 
of SSS Pneumo-  received  of SSS Pneumo- 
coccus I M of  7 days  coccus I M of 
later 
cc.  ! 
i 
0  10  -o  48  S[  S,----  --  l:500,O00dilu- 
normal control  10  -s  48 48148 --  -- --  tion 
mice)  10  -7  48 48 48--  -- 
:1,000dilution  10  -s  184848118  S  S 
10-'  48 48 48  48 48 48 
I0  "~  48 48 48  t8  S  S 
10  -5  484848  1848  S  l:l,000,000di- 
10  -4  48 48 48  18 48 48  lution 
10  -a  1818 241818 48 
l: 10,000  dilu- 
tion 
10  -s  4848 72  72  S  S 
10  -7  48 48 48  S  S  S 
10  -6  484848:72  S  S 
10  -5  484848,4~  t8  S  1:5,000,000di- 
10  -4  20 24 48 48 18 48  lution 
10  -~  18 18 20148 18 48 
[:50,000  dilu-  10 -s  48484848  S  S 
tion  10-'  4848 S  S  S  S 
10  -6  48 48 72  S l S  S 
10  -~  48 48 48  S IS  S  Dose washed 
10  -4  48 48 48 48148[  S  collodion particles 
SSS Pneumococcus 
i0 -a  20 48 48 4@ '48! 48  I M, measured in 
]  ]  density  of suspension 
[:100,000 dilu-  I0  -s  487272  S' S  S 
tion  10  -r  48 48 96  S  S  S 
10  -6  48484848  S;I  S  12,500M 
m 
10  -s  48 48 48 48,72 72 
10  -4  24 48 48 48  S  S 
10  -3  18 18 48 48  48148 
Dose of 
Pneumo- 
coccus I 
culture 
received 
7 days 
later 
C6. 
lO-S 
i0-~ 
10-6 
10--5 
10-~ 
lO-a 
lO-S 
10-' 
10--6 
10  -s 
10-4 
lO-Z 
lO-S 
I0-' 
10-6 
10-~ 
10-4 
10-6 
Dose of 
Pneumo- 
coccus I 
culture 
received 
7  days 
later 
CG. 
lO-S 
i0-7 
10-6 
10-5 
10-4 
10-3 
, 
961s  SSS 
7296  S i S  S  , 
4848  1848  S  • 
48 48  I~  72 96 
48 48,18 18 48 4~ 
18 18 !48  18 72 
i 
S  S  SlSlS 
96  S S S  i' S ¢~ 
4872  Si  S  S  ,¢ 
487296  S  S  .¢ 
487296  S  S 
48484848  18~ 
48SSSS~ 
489696  S  S 
484896  S  S 
1848S  S  S  ~ 
18 48 48 48i72 
18 48 48 48 48 I~ 
18 48  S  S  S  S 
18 48  S  S  S 
SSSSSfi 
184848  S  8  ~¢ 
1848S  S  SIS 
18 4848 --  ' 
i 
S  ffi  survived. 
Numeral  =  died, hours. 
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TABLE  VIII 
Immunization of Mice with Pneumococcus Type I  Polysaccharide Solution.  Com- 
parison of Polysaccharide Preparations as Immunizing Antigens 
Pneumococcus  I ~ ~ ~ ] 
I polysac-  ~ .~ 
charides  ~ ~ 
0 
(normal con- 
trol mice) 
1:150,000 
dilution 
1:1,500,00C 
dilution 
1:3,000,00~ 
dilution 
1:6,000,000 
dilution 
10  -9 36 36 
10  -s 36 36 
10  -7  24 24 
10  -s  36  S 
i0  -~ 36 36 
10  -~ 36 3~ 
10  -6  36 3~ 
10--4 20 36 
lO-S  _  _ 
I0-7  __  __ 
I0-~  _  _ 
I0-5  _  _ 
I0-~  _  _ 
10  -s  S  S 
10 -7 96  S 
10  -8  S  S 
10  -s  S 96 
10 -4 36 36 
10 -s 96  S 
I0  -7  S  S 
I0  -6  36 36 
I0 -5  36  S 
10 -4  36 36 
S  =  survived 
Numeral  -- died, 
-  -- not done. 
SSS Pnettmo- 
coccus  I  M 
3(SSS 
36  36 363C 
24  36136 3{ 
S -,-- 3( 
9(  SI  $9{ 
9(  SI  Sl3{ 
S  S2( 
fi 36 36[3{  3( 
....  3{ 
....  3{ 
....  3{ 
--  --,--  3( 
S--,-- 5 
S --,-- 9( 
96  --,-- 9( 
36  --,-- 24 
S  -,-  72 
S --,-- 72 
S  --,--  72 
T2  --,-- 72 
36  --,--  18 
SSS Pneumo- 
coccus I F 
S~  St  SI  S 
36136136148 
36136136148 
36[361 SIS 
SI  St SI  S 
361361  SI  S 
361361  SI  S 24 
361361361  S 24 
SI  SI  Si  $36 
421  SI  SI  $36 
SI  SI  SI  $36 
361361361  S 24 
36136136136 24 
SI  SI  S[  $36 
SI  SI  SI  $36 
sI  SI  SI  $36 
SI  SI  SI  $36 
241  S[  SI  $24 
SI  SI  S  $36 
sr  SI  S  $36 
si  SI  SI  SI36 
961  SI  SI  $36 
241361  Sl-120 
36 36 36 
36 36 36 
24 24 24 
24 ~24 
24 24 
36 36 
36 36 
36 36 
24 24 
24 24 
36 36 
36 48 
36 36 
36 36 
24 24 
48 72 
36 96 
3648 
36 36 
24 24 
sss Pneumococcus  I H 
! 
i 
36 36 36 72  S 
36 36 36 36 3~ 
36 36 36 36 3~ 
36 36 36 36 36 
24 24 24 24 36 
72  SSSS 
36 36 72 96  S 
36 36 36 36 48 
36 36 36 36 36 
24 24 24 36 36 
I~SSSS 
~696  S  S  S 
36172 72  S  S 
I 
18196  S  S  S 
36136 36 36 36 
721S  S  S  S 
siSSSS 
7219696  S  S 
36136 36 36 36 
24124 24 24 24 
hours. 
SSS 
36 96 96 
36 36 36 
36 36 36 
36 36 36 
SSSS 
SSSS 
SSSS 
36 36  S  S 
36SSS 
ssss 
ssss 
SISSS 
SISSS 
36136 36 36 
SISSS 
SISSS 
Sl  S  S  S 
721  SI  S  S 
~4136[361361 
SS 
SS 
SS 
36  S  S 
36  ;6 - 
S  S 
S  S 
S]  S 
SI  S 
SI  S 
SI  S 
Sl  S 
SI  S 
SJ  S 
S 
S  S 
S  S 
S  S 
S 
injection  of  the  homologous  specific polysaccharide.  The  dilutions 
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while an occasional survival was noted among the injected mice when 
tested  with  live  virulent  pneumococci these  were  too  irregular  to 
indicate any definite immunity in the groups. 
Pneumococcus Type I  Polysaccharide.--A preliminary test showed 
that although SSS Pneumococcus I  M,  the polysaccharide used for 
adsorption on the collodion particles in the preceding studies, produced 
no immunity when injected alone into mice in a  1:10,000 dilution, a 
1:150,000 dilution produced very definite immunity.  Similar results 
were obtained by Schiemann, Wadsworth and Brown, Salto and Ulrich 
and Enders but,  as mentioned before, by the use of specific carbo- 
hydrate  substances  derived  from  the  disrupted pneumococcus cell 
and assumed to be distinct from the specific soluble carbohydrate of 
Heidelberger and Avery. 
The comparative test shown in Table VIII was therefore carried 
out  with  the  three  Pneumococcus Type  I  polysaccharides already 
described.  The  dilution  which  produced  highest  immunity  was 
found to be 1:3,000,000.  A protection against 100 to  10,000 ~.F.D. 
was obtained by  a  single  injection of  1  cc.  of  this  dilution.  The 
variations observed in  the immunity produced by  the  polysaccha- 
rides  are  probably  due  to  difference  in  purity.  These polysac- 
charides were found by adsorption tests to absorb from monovalent 
Type I  serum precipitins against each.  After boiling for 1 hour at 
pH 9 their activity was retained both as shown by the precipitation 
reaction with homologous serum and by the production of immunity 
in  mice.  These polysaccharides differ,  therefore,  from both  the A 
substance of Enders and the antigenic carbohydrate of Wadsworth and 
Brown.  The immunity produced by  1,  2 or 3 weekly doses of the 
least pure of these polysaccharides, SSS Pneumococcus I F, proved to 
be  specific for Pneumococcus Type I.  An immunity was obtained 
against  10,000  ~.F.D.  of Type  I  pneumococcus culture  after  three 
weekly doses while no immunity could be demonstrated against live 
Pneumococcus Type II or Type III. 
The  time interval necessary for production of immunity by  this 
polysaccharide solution was investigated--a slight immunity is shown 
4 days after injection, reaching its height in 7 days and beginning to 
decrease after 2 weeks, though still demonstrable after 4 weeks. 
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centrations of the pneumococcus polysaccharide and described also by 
Felton (12) and Sia (13,  14) we gave to a group of mice an injection of 
a  polysaccharide solution of  1 : 10,000 dilution 1 week after the initial 
immunizing injection.  By protection  tests  we  found  the  resistance 
TABLE IX 
Optimum Dilution in the Immunization of Mice with Pneumococcus Polysaccharide 
Type II 
Dose of Pneu- 
Dose of SSS Pneu-  mococcus II 
mococcus II G  culture received 
1 cc. of  9 days later 
0 
(normal control 
mice) 
1:200,000 dilu- 
tion 
1:500,000 dilu- 
tion 
1:1,000,000 di- 
lution 
1:5,000,000 di- 
lution 
¢C. 
lO-g 
lO-S 
10-7 
10-s 
10-7 
i0  ~ 
10-5 
lO-S 
I0-7 
10  ~ 
10-~ 
lO-S 
I0-~ 
10--6 
10-6 
lO-S 
10-7 
10  ~ 
10-6 
48 
24 
48 
S 
24 
20 
36 
36 
36 
48 
48 
48 
48 
24 
24 
S 
48 
48 
48 
48 
S 
24 
24 
48 
48 
48 
24 
48 
48 
48 
48 
S 
S 
S 
72 
72 
48 
48 
S 
48 
72 
S 
S 
48 
72 
S 
S 
S 
S 
S  =  survived. 
Numeral  =  died, hours. 
was lowered from that effective against  10,000 M.]~.D. to one effective 
against 10 to 100 M.]r.D. 
Pneumococcus Type H  Polysaccharide.--Solutions of Pneumococcus 
Type  II  polysaccharide  SSS  Pneumococcus  II  G  (the  same  poly- 34  POLYSACCHARIDES  OF  PNEUMOCOCCI 
TABLE  X 
Specificity in the Immunization of Mice with Pneumococcus Type II Polysaccharide 
No. of weekly doses 
of 1 cc. of 
1:  2,000,000 SSS 
Pneumococcus  II G 
0 
normal control 
mice) 
0 
normal control 
mice) 
0 
normal control 
mice) 
Dose of Pneu- 
mococcus cul- 
ture received 
7 days after 
final injections 
CC. 
10-9 
10-8 
I0-~ 
10-8 
10-7 
10-8 
10-5 
10-4 
10-9 
lO-S 
i0-~ 
lO-S 
10-7 
10-6 
lO-S 
10-4 
10-8 
10-9 
10-8 
10-7 
10-s 
10-7 
10-~ 
10-~ 
10-* 
98  S 
48  48 
24  48 
48  S 
48  48 
48  96 
36  S 
36  36 
24  36 
36  S 
36  36 
72  72 
48  S 
48[  48 
48i  48 
48]  48 
48  I 72 
48 i  s 
I 
! 
Pneunlococcns 
I 
s!s  i 
sis 
SIS 
S  S 
S  :S 
721S 
i  i 
I 
S 
S 
Pneumococcus 
Type I  Type II 
24  S 
24  48 
24  i  48 
S 
S  24  48  S  S  S 
S  48  48  48  S  S 
24  24  48  S  S 
24  24  24  24  S 
36  72 
24  24 
24  24 
S 
S  36  36  S  S  S 
S  36  36!  72  S  S 
24  SIS  S  S 
36  36  36  S  S 
18  36  36  -- 
]  24  S 
]  24  24 
24  48 
! 
! 
--  72  S  S  -- 
S  24  96  S  S 
18  24  48  48  48 
Pneumo- 
coccus 
Type III 
24  48 
48  48 
24  48 
24  24  4 
24  24  2 
24  24  4 
S  S 
S  S 
24  S 
I 
I 
36:  S  S 
36:  S  S 
I 
I  I 
I 
48  48 
48  48 
2(]  24 
24  24  2, 
2{]  24  4 
S  =  survived. 
Numeral  =  died, hours. 
--  =  not done. 
saccharide  used  with  adsorbed  collodion  particles  in  Table  IV), 
when injected into  mice in  sufficiently high  dilutions,  produced  a 
definite immunity as shown in Table IX.  The immunity produced TABLE  XI 
Immunization of Mice with Pneumococcus Type III Polysaccharide 
Dose of SSS Pneu- 
mococcus  III H 
received  each  injec- 
tion 1 cc. of 
0 
(normal  control 
mice) 
1:300,000  dilu- 
tion 
1:3 M  dilution 
0 
(normal  control 
mice) 
1:300,000 
1:3 M dilution 
0 
(normal  control 
mice) 
1:300,000  dilu- 
tion 
1: 3 M  dilution 
Dose of cul- 
ture  received 
7  days after 
last  h~vction 
CC, 
i0-~ 
lO-S 
10-7 
lO-S 
i0-' 
i0  ~ 
I0  ~ 
I0-4 
lO-S 
I0-7 
10-9 
10-a 
10-7 
10-s 
10-7 
lO-S 
I0-' 
10-0 
10-s 
i0-~ 
10-s 
lO-r 
10-6 
lO-S 
10-7 
I0  ~ 
No. of weekly  immunizing  injeefions  received 
'  i  2  [  f 
Pneumococcus Type I 
48  S 
48  48[ 
48  48  1 
[ 
24  S  m  S 
s  48  S 
[ 
E 
48  48~  S 
48  48iS 
S  S 
48 
48  48 
48  48 
48  48 
48  48 
48  48 
S 
48 
48 
48 
48  S 
48  48 
48  48 
S  S 
48  S 
S  S 
48  48  72 
48  48  S 
48  S 
f 
Pneumococcus I 
48  48  F__ 
48  48  -- 
48  48  -- 
48  48  48 
48  72  72 
48  48  48 
48  48  481 
S 
S  18 
S  S 
72 
72 
18 
48 
S  S  S 
~rpe II 
72  48 
48  48 
48  48 
S  S  72 
S  S  S 
S  S  96 
S  S  48 
48  S  S 
48  S  48 
S 
48  S  [-- 
24  24  -- 
24  48  -- 
24  S  -- 
24  S  -- 
48  72  -- 
24148  -- 
48 
24 
24 
48 
S 
S 
24 
Pneumococcus Type III 
48[  s 
24  I48 
24  }24 
48  i48 
24  [48 
24  [24 
2448 
2448 
4848 
48 
48 
48 
48  48 
48  48 
48  -- 
48  24 
48  18 
48  -- 
S  -- 
48  -- 
48  -- 
48  48 
48  48 
24  48 
24  24 
S  S 
S  S 
72  S 
S  S 
18  S 
~6  S 
24  48 
S 
S 
72 
S 
48 
9,  S 
S  -- 
S  -- 
S  -- 
S  -- 
S  -- 
S  -- 
24 
48 
Sl-- 
S 
S 
S 
S  =  survived. 
Numeral  =  died, hours. 
--  =  not done, died in course of immunization. 
35 36  POLYSACCHARIDES  OF  PNEUMOCOCCI 
by  this  not  sufficiently purified polysaccharide was  found,  however, 
to  be  non-specific, protecting  against  Pneumococcus  Type  I  culture 
as well as Type II though not against Type III  (Table X).  However, 
as in the experience of Avery and his coworkers  (1,  2),  SSS Pneumo- 
TABLE  XII 
Immunization  of Mice with Carbon Adsorbed with Type III Pneuraococcua 
Polysaccharide 61153 and Solutions of Type III Pneumococcus 
Polysaccharide 61153 
Dose of SSS Pneu-  Dose of Pneu- 
mococcus nI 
mococcus HI 61153  culture injected  Immunizing  dose adsorbed on  Immunizing  dose in solution 
0.5 cc. injected  7 days after  carbon* 
weekly for 4 wks.  final  injection 
[:I0,000  dilu- 
tion 
t:lO0,O00  dilu- 
tion 
L: 1,000,000  di- 
lution 
0 
normal control) 
Carbon 44.4 mg. 
per cc. 
GC. 
lOiS 
10-~ 
lO-S 
I0-' 
10-6 
10-s 
10-7 
10-9 
10-s 
10-' 
10-s 
10-7 
48 
24 
48 
48 
24 
48 
24 
48 
48 
48 
48 
24 
48 
48 
48 
48 
24 
S 
48 
S 
48 
48 
48 
48 
48  48  48 
48  48  48 
48  48 
48  S  S 
24  S  S 
S  S  S 
48  72  S 
48  48  48 
48 
i 
48  48 
24  24 
24  48 
48  48 
48~  48 
24  48 
48 
48 
48 
48 
48 
48 
48  48 
48  48 
48  48 
48  48 
48]-- 
48  -- 
S  =  survived. 
Normal  -- died, hours. 
--  =  not done. 
* I gm. carbon adsorbed 22.5 rag. Pneumococcus III SSS 61153. 
I  gm.  carbon adsorbed with  Pneumococcus  III SSS 61153,  in 225  cc.  saline 
contains per cc. 44.4 rag. of carbon adsorbed with 0.I mg. of Pneumococcus III 
SSS or I part polysaccharide in 1,000. 
coccus II H, the purified carbohydrate received from Dr. Heidelberger, 
when injected in solution or adsorbed on collodion particles, produced 
no immunity  against pneumococci of any type. 
Pneumococcus  Type  III  Polysaccharide.--A  solution  of  Pneumo- JOS~  ZOZAYA  AND JANET CLARK  37 
coccus  Type  III  polysaccharide  SSS  Pneumococcus III  H  when 
injected into mice produced no definite immunity against the homol- 
ogous live culture.  However, as was the case when using this poly- 
saccharide adsorbed on collodion particles, a  definite immunity was 
demonstrable against  live  Pneumococcus Type I  culture  but  none 
against the Type II strain (Table XI). 
Immunization with Carbon Adsorbed with Pneumococcus  Type I  and I H 
Polysaceharides 
Washed suspensions of carbon adsorbed with Pneumococcus Type I 
polysaccharide  61002  and  solutions  of  the  same  polysaccharide, 
containing an amount of the specific carbohydrate per cc. equivalent 
to.the adsorbed carbohydrate content per cc. in the carbon suspensions, 
were injected into a  group of mice.  After 4 weekly injections tests 
were made for active immunity against live virulent Pneumococcus 
Type I.  No definite immunity was induced by  the polysaccharide 
in solution but an immunity to  1,000  ~r.r.D. was found in the mice 
injected with carbon with 1:100,000 polysaccharide adsorbed upon it. 
The same procedure was followed using a Pneumococcus Type III 
polysaccharide 61153  adsorbed on  carbon  and  unadsorbed.  Again 
the polysaccharide alone produced no immunity against the homol- 
ogous virulent organism, as had been the case with other preparations 
of Pneumococcus Type  III  polysaccharide.  However,  a  slight im- 
munity was observed in  the mice injected with the polysaccharide 
adsorbed on carbon in the higher dilutions (Table XII). 
DISCUSSION 
Two  groups  of workers have  attempted immunization with  the 
specific  polysaccharides  of  the  pneumococcus.  The  first  includes 
those who have prepared the carbohydrates by the original method 
of Avery and Heidelberger and the second those who have used other 
methods of preparation  involving especially  the  use  of  the  whole 
organism.  The latter no doubt obtained a different substance from 
the  one  originally  reported.  With  the  exception  of  the  human 
tests  reported  by  Tillett  and  Francis,  by  Finland  and  Sutliff 
and by ourselves (15), all attempts to immunize animals by the first 
group of workers have been negative.  The tests used as indicative 38  POL¥SACCHARIDES OF PNEU~OCOCCI 
of antibody response were mainly those for the presence of agglutinins 
and precipitins.  Of the second group of workers, Schiemann and his 
coworkers, Enders and Wadsworth and Brown have reported success- 
ful active immunization both in mice and in  rabbits.  The  special 
feature  of their method of immunization has  been  the  very  small 
dosages.  A  characteristic property of the polysaccharides used was 
that the immunizing value was lost when they were boiled in a weak 
alkaline solution. 
In the work here presented some of the polysaccharides used were 
either prepared by the original method or supplied through the kind- 
ness  of  Dr.  M.  Heidelberger.  All  of  our  specific  carbohydrates 
resisted boiling in weak alkaline solution and some of them had been 
in solution for over a year prior to their use for immunization. 
The  principal  considerations  in  our  work  were  the  relation  of 
dosages to  antibody response, the comparison of antibody response 
induced  by  the  polysaccharides in solution,  adsorbed on collodion 
particles  and on carbon,  and the utility of the protection test  for 
active  immunity in  the  detection of  this  antibody  response.  We 
observed marked difference in the antigenicity of the various poly- 
saccharides.  The only basis on which we can explain this is that some 
of  the  carbohydrates  have  lost  their  immunizing property  in  the 
process  of  purification  while  retaining  their  serological  activity. 
This explanation is, of course, only tentative. 
An  interesting  phenomenon  observed  was  the  cross-immunity 
against Pneumococcus Type I  obtained with Type III polysaccharide, 
while very little  or no immunity was found against Type III.  A 
similar cross-immunity to Pneumococcus Type I was produced by the 
Type II polysaccharide Lot G, as well as an immunity to the homol- 
ogous Type II organism.  In contrast to  this was  the  lack  of  im- 
munizing value  of  the  Type II  polysaccharide obtained  from Dr. 
Heidelberger.  The  possible  contamination  with  C  substance  of 
polysaccharide G could not account for this crossing, as we found no 
active  immunity to  any  of  the  type-specific pneumococci Type I, 
II or III in response to the injection of either degraded R pneumococci 
or C  substance in various dilutions.  The non-antigenicity of the C 
substance has also been noted by Tillett,  Goebel and Avery (16). 
The polysaccharides adsorbed on collodion and carbon were more J0Sl~.  ZOZAYA AND  JANET  CLARK  39 
regularly  antigenic.  The  injection  of  Type  III  polysaccharide  in 
various  dilutions  produced  no  immunity  against  the  homologous 
organism, but when it had been adsorbed on carbon a slight immunity 
was  noted.  The  same  was  true  with  one  preparation  of  Type  I 
polysaccharide.  These results are interesting in view of the fact that 
the  carbohydrates  are  irreversibly  adsorbed  on  the  carbon.  How 
these can then produce immunity it is difficult to say.  Conceivably 
the carbohydrate is eluted from the carbon in the body or the antibody 
is formed in situ on the particle. 
It is difficult to explain the optimum immunizing dose of the free 
polysaccharide.  In large doses it produces an increased susceptibility 
to  infection, in  small doses it  does not produce immunity.  These 
results suggest a  probable capacity of the host to  adsorb a  limited 
amount of the carbohydrate, which when injected in larger amounts 
affects  injuriously the  special  cells  concerned in  the  production of 
immunity, with the result that the animal becomes more susceptible 
to infection.  This may throw light on the course of events in pneu- 
monia and certain other diseases. 
CONCLUSIONS 
1.  Pneumococcus polysaccharides Types I, II and III adsorbed on 
collodion particles, and Types I  and III adsorbed on carbon (norit) 
are  antigenic in mice. 
2.  Unadsorbed pneumococcus polysaccharide of Type I is antigenic 
in mice in proper dilution.  One preparation of Type II polysaccharide 
was not antigenic, while another one immunized against Types I and 
II.  Type III polysaccharide was only slightly antigenic against Type 
III but immunized against Type I. 
3.  The  antigenicity  of  pneumococcus polysaccharide  in  optimal 
dosage is tentatively explained by an adsorption phenomenon taking 
place in the body in instances in which the polysaccharides had not 
been adsorbed before injection. 
4.  The aggressin-like action of large doses of pneumococcus  poly- 
saccharides Types I, II and III is further established. 40  POLYSACCHARIDES OF  PNEUMOCOCCI 
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